Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

12.29
-1.1700-8.69%
Post-market: 13.000.7100+5.78%19:56 EDT
Volume:1.97M
Turnover:25.02M
Market Cap:719.36M
PE:-1.38
High:14.05
Open:14.05
Low:12.09
Close:13.46
52wk High:16.85
52wk Low:5.00
Shares:58.53M
Float Shares:40.28M
Volume Ratio:1.32
T/O Rate:4.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.9193
EPS(LYR):-10.5411
ROE:-57.76%
ROA:-16.99%
PB:1.11
PE(LYR):-1.17

Loading ...

Company Profile

Company Name:
Ginkgo Bioworks Holdings Inc.
Exchange:
NYSE
Establishment Date:
2008
Employees:
834
Office Location:
27 Drydock Avenue,8th Floor,Boston,Massachusetts,United States
Zip Code:
02210
Fax:
- -
Introduction:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Directors

Name
Position
Jason Kelly
Chief Executive Officer, Founder and Director
Marijn Dekkers
Director,Chairman
Reshma Shetty
President, Chief Operating Officer, Founder and Director
Arie Belldegrun
Director
Christian Henry
Director
Harry E. Sloan
Director
Reshma Kewalramani
Director
Shyam Sankar
Director

Shareholders

Name
Position
Jason Kelly
Chief Executive Officer, Founder and Director
Reshma Shetty
President, Chief Operating Officer, Founder and Director
Mark Dmytruk
Chief Financial Officer